Drs. Banerji have had many more scientific papers and monographs published, and delivered lectures and presented papers at prestigious international conferences, symposia and seminars in the USA, Canada, Spain, Portugal, Italy, Holland, Turkey, Japan and Brazil.

PBHRF are in the process of holding discussions with various institutions, including the National Cancer Institute (NCI), The University of Texas MD Anderson Cancer Center, the Columbia University and others regarding various collaborative research projects, and have received offers of assistance from companies like Boiron (internationally well-known manufactures of homeopathic medicines), both in Spain and France.

The team from Columbia University visited the PBHRF clinic in 2007


Since then, PBHRF have had many visitors from the United States of America, including Dr. Jeffrey White, MD, Director, Office of Cancer Complementary and Alternative Medicine, National Cancer Institute; Dr. Moshe Frenkel, Associate Professor of Integrative Medicine and Medical Director of the Integrative Medicine Program, Division of Cancer Medicine Department of Palliative Care and Rehabilitation Medicine at The University of Texas M D Anderson Cancer Center; Dr. Elena Ladas, MS, RD, Director, and Dr. Kara M. Kelly, MD, Medical Director of the Integrative Therapies Program for Children with Cancer, Division of Pediatric Oncology, and others from Columbia University; and Dr. Barbara Sarter, now at the University of San Diego, who spent five months in Kolkata to study the Banerji Protocols and work with us when she held a faculty position in the Department of Family Medicine at the University of Southern California.
Spain has assumed great importance in recent years… Drs. Banerji and the PBHRF have been deeply involved in popularising treatment under the Banerji Protocols, based on the use of ultradilute or homeopathic medicines in Spain – and, by extension, to other Spanish-speaking countries – where they have received tremendous response. In 2008, a three-member cancer support team from Spain undertook a week-long visit to PBHRF to acquire first-hand knowledge about the Banerji Protocols; two hold senior positions at the University of Barcelona, while the third runs a Valencia-based web portal for cancer support, which is visited by nearly 1000 persons daily, not only in Spain, but also in Spanish-speaking countries elsewhere in the world – with many enquiries on the Banerji Protocols.
The response of Spanish homeopaths, pharmacists and patients to the Banerji Protocols has been extremely enthusiastic. In 2008, Drs. Banerji made a presentation at a conference exclusively for classical homeopaths who enthusiastically welcomed the Banerji Protocols. A documentary film on Dr. Prasanta Banerji is now being made by two Spanish documentary film makers who have undertaken visits to Kolkata and Mihijam.
Drs. Banerji have visited Japan several times, and there are excellent prospects for the popularization of treatment in this country using the Banerji Protocols. They hold the same opinion with regard to Canada, Germany, Italy and Holland which they visited this year (2012).